Mesenchymal stem cells (MSC) are promising tools in the fields of cell therapy and regenerative medicine. In addition to their differentiation potential, MSC have the ability to secrete bioactive molecules that stimulate tissue regeneration. Thus, the overexpression of cytokines and growth factors may enhance the therapeutic effects of MSC. Here we generated and characterized mouse bone marrow MSC lines overexpressing hG-CSF or hIGF-1. MSC lines overexpressing hG-CSF or hIGF-1 were generated through lentiviral vector mediated gene transfer. The expression of hG-CSF or hIGF-1 genes in the clones produced was quantified by qRT-PCR, and the proteins were detected in the cell supernatants by ELISA. The cell lines displayed cell surface markers and differentiation potential into adipocytes, osteocytes and chondrocytes similar to the control MSC cell lines, indicating the conservation of their phenotype even after genetic modification. IGF-1 and G-CSF transgenic cells maintained immunosuppressive activity. Finally, we performed a comparative gene expression analysis by qRT-PCR array in the cell lines expressing hIGF-1 and hG-CSF when compared to the control cells. Our results demonstrate that the cell lines generated may be useful tools for cell therapy and are suitable for testing in disease models.
Mesenchymal stem cells Growth factors G-CSF IGF-1
This is a preview of subscription content, log in to check access.
This work was supported by The National Council for Scientific and Technological Development (CNPq), The Foundation of Support for Research of the State of Bahia (FAPESB), and Funding Authority for Studies and Projects (FINEP).
Haider HKh, Jiang S et al (2008) IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103:1300–1308CrossRefGoogle Scholar
Harada M, Qin Y et al (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11:305–311. doi:10.1038/nm1199CrossRefGoogle Scholar
Macambira SG, Vasconcelos JF et al (2009) Granulocyte colony-stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function. FASEB J 23:3843–3850. doi:10.1096/fj.09-137869CrossRefGoogle Scholar
McGinley LM, Sims E et al (2016) Human cortical neural stem cells expressing insulin-like growth factor-I: a novel cellular therapy for Alzheimer’s disease. Stem Cells Transl Med 5:379–391. doi:10.5966/sctm.2015-0103CrossRefGoogle Scholar
Pittenger MF, Mackay AM et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147CrossRefGoogle Scholar
Ponte AL, Ribeiro-Fleury T et al (2012) Granulocyte-colony-stimulating factor stimulation of bone marrow mesenchymal stromal cells promotes CD34+ cell migration via a matrix metalloproteinase-2-dependent mechanism. Stem Cells Dev 21:3162–3172. doi:10.1089/scd.2012.0048CrossRefGoogle Scholar
Porada CD, Stem C et al (2013) Gene therapy: the promise of a permanent cure. N C Med J 74:526–529Google Scholar
Schmidt MB, Chen EH et al (2006) A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthr Cartil 14:403–412. doi:10.1016/j.joca.2005.10.011CrossRefGoogle Scholar
Tomasoni S, Longaretti L et al (2013) Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 22:772–780. doi:10.1089/scd.2012.0266CrossRefGoogle Scholar
Wang Y, Chen X et al (2014) Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol 15:1009–1016. doi:10.1038/ni.3002CrossRefGoogle Scholar
White SM, Renda M et al (1999) Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol 73:2832–2840Google Scholar
Xinaris C, Morigi M et al (2013) A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. Cell Transplant 22:423–436CrossRefGoogle Scholar
Yang Q, Yang Y et al (2016) Effects of granulocyte colony-stimulating factor on patients with liver failure: a meta-analysis. J Clin Transl Hepatol 4:90–96. doi:10.14218/JCTH.2016.00012Google Scholar
Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92:1472–1489CrossRefGoogle Scholar
Zhu M, Feng Y et al (2015) Human cerebrospinal fluid regulates proliferation and migration of stem cells through insulin-like growth factor-1. Stem Cells Dev 24:160–171CrossRefGoogle Scholar